世界の硬化療法市場2020:製造企業別、地域別、種類別、用途別、市場予測2025

GlobalInfoResearchが発行した調査報告書(GIR20OC09897)
◆英語タイトル:Global Sclerotherapy Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20OC09897
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年10月(※2024年版があります。お問い合わせください。)
◆ページ数:103
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本書では、硬化療法の世界市場を調査対象にし、硬化療法の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(洗剤、浸透圧剤、化学刺激剤)、用途別分析(静脈疾患、消化管出血、気管支瘻、嚢胞性疾患)、市場予測(2021年~2025年)、販売チャンネル・代理店分析情報などを整理しました。
・市場概要
・メーカー情報:BTG、Angiodynamics、Troikaa、Kreussler、Omega Pharmaceuticals、LGM Pharma、MTW ENDOSKOPIE、Bioniche Pharma Group Ltd、Changan Tianyu group、ENDO-FLEX、Cook Medical
・メーカー別販売量、売上、市場シェア
・硬化療法の地域別市場分析
・硬化療法の北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・硬化療法のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・硬化療法のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・硬化療法の南米市場規模2015-2020:ブラジル、アルゼンチンなど
・硬化療法の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・硬化療法の種類別市場規模2015-2020:洗剤、浸透圧剤、化学刺激剤
・硬化療法の用途別市場規模2015-2020:静脈疾患、消化管出血、気管支瘻、嚢胞性疾患
・硬化療法の世界市場予測2021-2025:地域別、種類別、用途別
・販売チャンネル・代理店分析
・調査の結果・結論
【レポートの概要】

Market Overview
The Sclerotherapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Sclerotherapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
Sclerotherapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Sclerotherapy market has been segmented into
Detergents
Osmotic agents
Chemical irritants

By Application, Sclerotherapy has been segmented into:
Venous disease
Gastrointestinal bleeding
Bronchopleural fistula
Cystic disease

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Sclerotherapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Sclerotherapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Sclerotherapy market.

The report offers in-depth assessment of the growth and other aspects of the Sclerotherapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Sclerotherapy Market Share Analysis
Sclerotherapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Sclerotherapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Sclerotherapy sales, revenue and market share for each player covered in this report.

The major players covered in Sclerotherapy are:
BTG
Angiodynamics
Troikaa
Kreussler
Omega Pharmaceuticals
LGM Pharma
MTW ENDOSKOPIE
Bioniche Pharma Group Ltd
Changan Tianyu group
ENDO-FLEX
Cook Medical

Among other players domestic and global, Sclerotherapy market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sclerotherapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Sclerotherapy, with price, sales, revenue and global market share of Sclerotherapy in 2018 and 2019.
Chapter 3, the Sclerotherapy competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sclerotherapy breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Sclerotherapy market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Sclerotherapy sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 Sclerotherapy Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Sclerotherapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Detergents
1.2.3 Osmotic agents
1.2.4 Chemical irritants
1.3 Market Analysis by Application
1.3.1 Overview: Global Sclerotherapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Venous disease
1.3.3 Gastrointestinal bleeding
1.3.4 Bronchopleural fistula
1.3.5 Cystic disease
1.4 Overview of Global Sclerotherapy Market
1.4.1 Global Sclerotherapy Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 BTG
2.1.1 BTG Details
2.1.2 BTG Major Business
2.1.3 BTG SWOT Analysis
2.1.4 BTG Product and Services
2.1.5 BTG Sclerotherapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Angiodynamics
2.2.1 Angiodynamics Details
2.2.2 Angiodynamics Major Business
2.2.3 Angiodynamics SWOT Analysis
2.2.4 Angiodynamics Product and Services
2.2.5 Angiodynamics Sclerotherapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Troikaa
2.3.1 Troikaa Details
2.3.2 Troikaa Major Business
2.3.3 Troikaa SWOT Analysis
2.3.4 Troikaa Product and Services
2.3.5 Troikaa Sclerotherapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Kreussler
2.4.1 Kreussler Details
2.4.2 Kreussler Major Business
2.4.3 Kreussler SWOT Analysis
2.4.4 Kreussler Product and Services
2.4.5 Kreussler Sclerotherapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Omega Pharmaceuticals
2.5.1 Omega Pharmaceuticals Details
2.5.2 Omega Pharmaceuticals Major Business
2.5.3 Omega Pharmaceuticals SWOT Analysis
2.5.4 Omega Pharmaceuticals Product and Services
2.5.5 Omega Pharmaceuticals Sclerotherapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 LGM Pharma
2.6.1 LGM Pharma Details
2.6.2 LGM Pharma Major Business
2.6.3 LGM Pharma Product and Services
2.6.4 LGM Pharma Sclerotherapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 MTW ENDOSKOPIE
2.7.1 MTW ENDOSKOPIE Details
2.7.2 MTW ENDOSKOPIE Major Business
2.7.3 MTW ENDOSKOPIE Product and Services
2.7.4 MTW ENDOSKOPIE Sclerotherapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bioniche Pharma Group Ltd
2.8.1 Bioniche Pharma Group Ltd Details
2.8.2 Bioniche Pharma Group Ltd Major Business
2.8.3 Bioniche Pharma Group Ltd Product and Services
2.8.4 Bioniche Pharma Group Ltd Sclerotherapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Changan Tianyu group
2.9.1 Changan Tianyu group Details
2.9.2 Changan Tianyu group Major Business
2.9.3 Changan Tianyu group Product and Services
2.9.4 Changan Tianyu group Sclerotherapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 ENDO-FLEX
2.10.1 ENDO-FLEX Details
2.10.2 ENDO-FLEX Major Business
2.10.3 ENDO-FLEX Product and Services
2.10.4 ENDO-FLEX Sclerotherapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Cook Medical
2.11.1 Cook Medical Details
2.11.2 Cook Medical Major Business
2.11.3 Cook Medical Product and Services
2.11.4 Cook Medical Sclerotherapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Sclerotherapy Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Sclerotherapy Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Sclerotherapy Manufacturer Market Share in 2019
3.3.2 Top 6 Sclerotherapy Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Sclerotherapy Sales, Revenue and Market Share by Regions
4.1.1 Global Sclerotherapy Sales and Market Share by Regions (2015-2020)
4.1.2 Global Sclerotherapy Revenue and Market Share by Regions (2015-2020)
4.2 North America Sclerotherapy Sales and Growth Rate (2015-2020)
4.3 Europe Sclerotherapy Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Sclerotherapy Sales and Growth Rate (2015-2020)
4.5 South America Sclerotherapy Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Sclerotherapy Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Sclerotherapy Sales, Revenue and Market Share by Country
5.1.1 North America Sclerotherapy Sales and Market Share by Country (2015-2020)
5.1.2 North America Sclerotherapy Revenue and Market Share by Country (2015-2020)
5.2 United States Sclerotherapy Sales and Growth Rate (2015-2020)
5.3 Canada Sclerotherapy Sales and Growth Rate (2015-2020)
5.4 Mexico Sclerotherapy Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Sclerotherapy Sales, Revenue and Market Share by Country
6.1.1 Europe Sclerotherapy Sales and Market Share by Country (2015-2020)
6.1.2 Europe Sclerotherapy Revenue and Market Share by Country (2015-2020)
6.2 Germany Sclerotherapy Sales and Growth Rate (2015-2020)
6.3 UK Sclerotherapy Sales and Growth Rate (2015-2020)
6.4 France Sclerotherapy Sales and Growth Rate (2015-2020)
6.5 Russia Sclerotherapy Sales and Growth Rate (2015-2020)
6.6 Italy Sclerotherapy Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Sclerotherapy Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Sclerotherapy Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Sclerotherapy Revenue and Market Share by Regions (2015-2020)
7.2 China Sclerotherapy Sales and Growth Rate (2015-2020)
7.3 Japan Sclerotherapy Sales and Growth Rate (2015-2020)
7.4 Korea Sclerotherapy Sales and Growth Rate (2015-2020)
7.5 India Sclerotherapy Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Sclerotherapy Sales and Growth Rate (2015-2020)
7.7 Australia Sclerotherapy Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Sclerotherapy Sales, Revenue and Market Share by Country
8.1.1 South America Sclerotherapy Sales and Market Share by Country (2015-2020)
8.1.2 South America Sclerotherapy Revenue and Market Share by Country (2015-2020)
8.2 Brazil Sclerotherapy Sales and Growth Rate (2015-2020)
8.3 Argentina Sclerotherapy Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Sclerotherapy Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Sclerotherapy Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Sclerotherapy Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Sclerotherapy Sales and Growth Rate (2015-2020)
9.3 Turkey Sclerotherapy Sales and Growth Rate (2015-2020)
9.4 Egypt Sclerotherapy Sales and Growth Rate (2015-2020)
9.5 South Africa Sclerotherapy Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Sclerotherapy Sales and Market Share by Type (2015-2020)
10.2 Global Sclerotherapy Revenue and Market Share by Type (2015-2020)
10.3 Global Sclerotherapy Price by Type (2015-2020)
11 Global Sclerotherapy Market Segment by Application
11.1 Global Sclerotherapy Sales Market Share by Application (2015-2020)
11.2 Global Sclerotherapy Revenue Market Share by Application (2015-2020)
11.3 Global Sclerotherapy Price by Application (2015-2020)
12 Market Forecast
12.1 Global Sclerotherapy Sales, Revenue and Growth Rate (2021-2025)
12.2 Sclerotherapy Market Forecast by Regions (2021-2025)
12.2.1 North America Sclerotherapy Market Forecast (2021-2025)
12.2.2 Europe Sclerotherapy Market Forecast (2021-2025)
12.2.3 Asia-Pacific Sclerotherapy Market Forecast (2021-2025)
12.2.4 South America Sclerotherapy Market Forecast (2021-2025)
12.2.5 Middle East & Africa Sclerotherapy Market Forecast (2021-2025)
12.3 Sclerotherapy Market Forecast by Type (2021-2025)
12.3.1 Global Sclerotherapy Sales Forecast by Type (2021-2025)
12.3.2 Global Sclerotherapy Market Share Forecast by Type (2021-2025)
12.4 Sclerotherapy Market Forecast by Application (2021-2025)
12.4.1 Global Sclerotherapy Sales Forecast by Application (2021-2025)
12.4.2 Global Sclerotherapy Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の硬化療法市場2020:製造企業別、地域別、種類別、用途別、市場予測2025(Global Sclerotherapy Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。